| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/28/2013 | US20130052734 Method for preparing regulatory dendritic cells |
| 02/28/2013 | US20130052733 Antigen presenting composition and use thereof |
| 02/28/2013 | US20130052732 Dna-damage-induced proteolysis |
| 02/28/2013 | US20130052731 HUMANIZED LEWIS-Y SPECIFIC ANTIBODY-BASED DELIVERY OF DICER SUBSTRATE siRNA (D-siRNA) AGAINST STAT3 |
| 02/28/2013 | US20130052730 Methods and system for cryogenic preservation of cells |
| 02/28/2013 | US20130052729 Method for preparing induced paraxial mesoderm progenitor (ipam) cells and their use |
| 02/28/2013 | US20130052728 Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells |
| 02/28/2013 | US20130052727 Compositions and methods for autologous germline mitochondrial energy transfer |
| 02/28/2013 | US20130052717 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 02/28/2013 | US20130052716 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 02/28/2013 | US20130052712 Surface immobilization of various functional biomolecules using mussel adhesive protein |
| 02/28/2013 | US20130052699 Biocatalysts for ezetimibe synthesis |
| 02/28/2013 | US20130052692 Host Cells and Methods for Producing 1-Deoxyxylulose 5-phosphate (DXP) and/or a DXP Derived Compound |
| 02/28/2013 | US20130052685 Prevention and treatment of complement-associated eye conditions |
| 02/28/2013 | US20130052683 Production of galactosylated n-glycans in plants |
| 02/28/2013 | US20130052679 L-threonine analysis method and l-threonine dehydrogenase |
| 02/28/2013 | US20130052676 Composition and Method for Assessing Regulation of Mast Cells |
| 02/28/2013 | US20130052666 Antibody against human tsh and canine tsh |
| 02/28/2013 | US20130052663 Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors |
| 02/28/2013 | US20130052660 Method for detecting protein-protein interactions in cells |
| 02/28/2013 | US20130052647 Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
| 02/28/2013 | US20130052643 Method for generating nuclear reprogrammed cell, and use thereof |
| 02/28/2013 | US20130052642 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs) |
| 02/28/2013 | US20130052634 Hcv genotype 4 replicons |
| 02/28/2013 | US20130052633 Hcv genotype 3 replicons |
| 02/28/2013 | US20130052329 Tomato variety nun 0030 me |
| 02/28/2013 | US20130052272 Pharmaceutical compositions and methods for the treatment and prevention of cancer |
| 02/28/2013 | US20130052270 Use of Gold Nanoclusters in Ameliorating Oxidate Stress and/or Aging |
| 02/28/2013 | US20130052268 Compositions and methods for treatment of parkinson's disease |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052254 System and method for a piezoelectric scaffold for tissue growth and repair |
| 02/28/2013 | US20130052240 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 02/28/2013 | US20130052232 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 02/28/2013 | US20130052226 Compositions and methods for preventing or treating a human parvovirus infection |
| 02/28/2013 | US20130052217 Tumor vaccination involving a humoral immune response against self-proteins |
| 02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
| 02/28/2013 | US20130052215 Tumor vaccine |
| 02/28/2013 | US20130052212 Method for allogeneic cell therapy |
| 02/28/2013 | US20130052211 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 02/28/2013 | US20130052210 Use of ccl1 in therapy |
| 02/28/2013 | US20130052203 In vivo screening models for treatment of qc-related disorders |
| 02/28/2013 | US20130052202 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052199 Molecular Determinants of Myeloma Bone Disease and Uses Thereof |
| 02/28/2013 | US20130052197 Novel anti-cd98 antibody and use thereof |
| 02/28/2013 | US20130052196 Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 02/28/2013 | US20130052194 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same |
| 02/28/2013 | US20130052193 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR TOLL-LIKE RECEPTOR 2 (TLR2) |
| 02/28/2013 | US20130052192 Activatable Constructs |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052187 Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions |
| 02/28/2013 | US20130052181 Combined use of ribonuclease and artemisinin |
| 02/28/2013 | US20130052179 Arginine deiminase mutant and preparation and application thereof |
| 02/28/2013 | US20130052174 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052169 Stem cell bank for personalized medicine |
| 02/28/2013 | US20130052168 Methods and compositions for tissue regeneration |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052157 Use of il-17e for cancer treatment |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052128 Upar Binding Agents and Methods of Use Thereof |
| 02/28/2013 | DE102011111631A1 Verfahren zur Herstellung von Medikamenten zur Tumorbekämpfung Process for the preparation of drugs for combating tumors |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2845884A1 Clostridium difficile antibodies |
| 02/28/2013 | CA2845682A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
| 02/28/2013 | CA2844779A1 Neurogenic and gliogenic factors and assays therefor |
| 02/27/2013 | EP2562253A1 Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these |
| 02/27/2013 | EP2562248A1 Differentiation of human embryonic stem cells |
| 02/27/2013 | EP2562187A1 Anti-CD37 antibodies |
| 02/27/2013 | EP2561887A2 Cancer therapy sensitizer |
| 02/27/2013 | EP2561829A1 Tool for transferring membranous tissue, kit and method for transferring membranous tissue |
| 02/27/2013 | EP2561087A2 Physiological methods for isolation of high purity cell populations |
| 02/27/2013 | EP2561066A1 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/27/2013 | EP2561065A2 Cell culture medium comprising small peptides |
| 02/27/2013 | EP2560689A1 Novel self-assembling peptides and their use in the formation of hydrogels |
| 02/27/2013 | EP2560478A1 Combinations including cry3aa and cry6aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2560477A1 Combinations including cry34ab/35ab and cry6aaproteins to prevent development of resistance in corn rootworms(diabrotica spp.) |
| 02/27/2013 | EP2560476A1 Combinations including cry34ab/35ab and cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2560475A1 Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2093286B1 Multi-chain eukaryotic display vectors and uses thereof |
| 02/27/2013 | CN102947702A New methods for isolating tr1 cells |
| 02/27/2013 | CN102947463A Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe |
| 02/27/2013 | CN102947450A Rna preparations comprising purified modified rna for reprogramming cells |
| 02/27/2013 | CN102947447A Glycerol-3-phosphate acyltransferase homologue and use thereof |
| 02/27/2013 | CN102947444A Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 02/27/2013 | CN102947325A Cdca5 peptides and vaccines including the same |
| 02/27/2013 | CN102946915A Methods, substrates, and systems useful for cell seeding of medical grafts |
| 02/27/2013 | CN102946914A Methods and combination |
| 02/27/2013 | CN102946717A Combinations including Cry34Ab/35Ab and Cry6Aa proteins to prevent development of resistance corn rootworms(Diabrotica spp.) |
| 02/27/2013 | CN102946716A Combinations including Cry3Aa and Cry6Aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | CN102944684A A and B-type blood type resistant sizing reagent |
| 02/27/2013 | CN102943081A Deoxyribose nucleic acid (DNA) sequence for encoding parietchloris incise diacylglycerol acyltransferase and application thereof |
| 02/27/2013 | CN102943080A Corn ZmCIPK12 gene and applications thereof |
| 02/27/2013 | CN102943075A Gossypium hirsutum GhTCP2 gene promoter and application thereof |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102943066A Human apolipoprotein B100 (ApoB100) monoclonal antibody and chemiluminescence immune assay determination kit adopting the human ApoB100 monoclonal antibody |
| 02/27/2013 | CN102943065A Cell strain of giant cell tumor of human bone and application thereof |
| 02/27/2013 | CN102943064A Method for efficiently differentiating and amplifying CD4 positive T cells from hematopoietic stem cells |
| 02/27/2013 | CN102943063A Treatment method for improving myocardial cell protective capability and transfer ability of bone marrow mononuclear cells |
| 02/27/2013 | CN102943062A Building method of cell model for performing rat renal tubular epithelial cell ischemic postconditioning |